Segall Bryant & Hamill LLC Lowers Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Segall Bryant & Hamill LLC lowered its position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 25.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 333,444 shares of the medical instruments supplier's stock after selling 116,778 shares during the quarter. ICU Medical makes up approximately 0.8% of Segall Bryant & Hamill LLC's portfolio, making the stock its 9th biggest position. Segall Bryant & Hamill LLC owned about 1.37% of ICU Medical worth $60,760,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in ICUI. Vanguard Group Inc. boosted its stake in shares of ICU Medical by 0.5% during the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier's stock valued at $263,226,000 after purchasing an additional 11,991 shares during the period. Dimensional Fund Advisors LP grew its holdings in ICU Medical by 21.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier's stock worth $36,996,000 after acquiring an additional 55,588 shares during the last quarter. Silvercrest Asset Management Group LLC increased its position in shares of ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier's stock valued at $29,882,000 after acquiring an additional 145,485 shares during the period. WCM Investment Management LLC raised its stake in shares of ICU Medical by 1.3% during the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier's stock valued at $45,272,000 after acquiring an additional 3,407 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of ICU Medical by 11.5% during the second quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier's stock worth $25,710,000 after purchasing an additional 22,310 shares during the period. Institutional investors own 96.10% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Jefferies Financial Group initiated coverage on ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price target for the company. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday. KeyCorp boosted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a research note on Wednesday, November 13th. Finally, Raymond James lifted their price objective on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $173.00.

ICU Medical Stock Down 2.6 %

NASDAQ ICUI traded down $4.47 during trading hours on Wednesday, reaching $165.23. 94,125 shares of the company's stock traded hands, compared to its average volume of 274,192. The firm has a market cap of $4.04 billion, a PE ratio of -37.13 and a beta of 0.66. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. ICU Medical, Inc. has a 52-week low of $82.82 and a 52-week high of $196.26. The firm has a 50-day simple moving average of $176.59 and a 200 day simple moving average of $144.30.

Insider Activity

In other news, VP Daniel Woolson sold 2,502 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the sale, the vice president now directly owns 13,107 shares of the company's stock, valued at approximately $2,139,324.54. This represents a 16.03 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $18,665,666.78. This represents a 10.29 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 38,502 shares of company stock worth $6,573,496. Insiders own 6.70% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.